β-Globin mRNA decay in erythroid cells: UG site-preferred endonucleolytic cleavage that is augmented by a premature termination codon
- Audrey Stevens*,
- Yang Wang†,
- Kirsten Bremer‡,
- Jing Zhang†,
- Robert Hoepfner‡,
- Michael Antoniou§,
- Daniel R. Schoenberg‡,¶, and
- Lynne E. Maquat†,‖,**
- *Life Sciences Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831; †Department of Cancer Genetics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263; ‡Department of Molecular and Cellular Biochemistry and Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210; §Division of Medical and Molecular Genetics, GKT School of Medicine, Guy's Hospital, London SE1 9RT, United Kingdom; and ‖Department of Biochemistry and Biophysics, School of Medicine and Dentistry, University of Rochester, 601 Elmwood Avenue, Rochester, NY 14642
-
Contributed by Audrey Stevens
Abstract
Previous work showed that human β-globin mRNAs harboring a premature termination codon are degraded in the erythroid tissues of mice to products that lack sequences from the mRNA 5′ end but contain a 5′ cap-like structure. Whether these decay products are the consequence of endonucleolytic or 5′-to-3′ exonucleolytic activity is unclear. We report that this β-globin mRNA decay pathway is recapitulated in cultured mouse erythroleukemia (MEL) cells and targets nonsense-free mRNA to a lesser extent than nonsense-containing mRNA. S1 nuclease mapping and primer extension demonstrated that 70–80% of decay product 5′ ends contain a UG dinucleotide. Detection of upstream counterparts of these decay products indicates that they are generated by endonucleolytic activity. Both crude and partially purified polysome extracts prepared from MEL cells contain an endonucleolytic activity that generates decay products comparable to those observed in vivo. These data suggest that an endonuclease with preference for UG dinucleotides is involved in the degradation of nonsense-containing and, to a lesser extent, nonsense-free human β-globin mRNAs in mouse erythroid cells.
Footnotes
-
↵ ¶ To whom reprint requests should be addressed at: Department of Molecular and Cellular Biochemistry, Ohio State University, 364 Hamilton Hall, 1645 Neil Avenue, Columbus, OH 43210-1218. E-mail: schoenberg.3{at}osu.edu.
-
↵ ** Present address: Department of Biochemistry and Biophysics, School of Medicine and Dentistry, University of Rochester, 601 Elmwood Avenue, Rochester, NY 14642.
- Abbreviations:
- MEL,
- mouse erythroleukemia;
- PMR1,
- polysome ribonuclease 1;
- NMD,
- nonsense-mediated mRNA decay;
- thal,
- thalassemic;
- TG,
- transgenic
- Copyright © 2002, The National Academy of Sciences





